Qube Research & Technologies (QRT)
CASI

Qube Research & Technologies (QRT)’s CASI Pharmaceuticals CASI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$550 – 3379
2024
Q2 		$550 Buy
+100
New +$311 ﹤0.01% 3307
2023
Q4 		– Sell
-328
Closed -$840 – 4367
2023
Q3 		$840 Buy
+328
New +$777 ﹤0.01% 3643
2021
Q4 		– Sell
-1,051
Closed -$13K – 2561
2021
Q3 		$13K Buy
+1,051
New +$14.2K ﹤0.01% 2014

Other funds holding CASI

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CASI Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of CASI Pharmaceuticals (CASI) in Q3 2024, closing a stake of 100 shares — an estimated $550 sold.

Qube Research & Technologies (QRT) first reported a position in CASI in Q3 2021 and held it in 3 quarters. The position peaked at $13K in Q3 2021. 20 funds tracked by Wall St. Rank hold CASI as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining CASI Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 100 CASI Pharmaceuticals shares in Q3 2024, an estimated $550.
  • Qube Research & Technologies (QRT) first reported a position in CASI Pharmaceuticals in Q3 2021 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s CASI Pharmaceuticals position peaked at $13K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.